{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:03:58Z","timestamp":1761764638184,"version":"3.32.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1007\/s00120-006-1000-3","type":"journal-article","created":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T20:32:16Z","timestamp":1138221136000},"page":"167-174","source":"Crossref","is-referenced-by-count":4,"title":["Intravesikale Therapie der \u00fcberaktiven Blase","Intravesical therapy for overactive bladder"],"prefix":"10.1007","volume":"45","author":[{"given":"J.","family":"Pannek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Grigoleit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Wormland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Goepel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1000_CR1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0022-5347(01)62703-4","volume":"160","author":"Buyse","year":"1998","unstructured":"Buyse G, Verpoorten C, Vereecken, R, Casaer P (1998) Intravesical application of a stable oxybutinin solution improves therapeutic compliance and acceptance in children with neurogenic bladder dysfunction. J Urol 160: 1084\u20131087","journal-title":"J Urol"},{"key":"1000_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0090-4295(01)01638-7","volume":"59","author":"Cruz","year":"2002","unstructured":"Cruz F (2002) Vanilloid receptor and detrusor instability. Urology 59(Suppl 5A): 51\u201360","journal-title":"Urology"},{"key":"1000_CR3","first-page":"251","volume":"171","author":"De","year":"2004","unstructured":"De S\u00e9ze M, Wiart L, de S\u00e9ze MP et al. (2004) Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study. J Urol 171: 251\u2013255","journal-title":"J Urol"},{"key":"1000_CR4","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1046\/j.1464-410X.1997.32419.x","volume":"79","author":"Fontanella","year":"1997","unstructured":"Fontanella UA, Rossi CA, Stephen RL (1997) Bladder and urethral anestesia with electromotive drug administration (EMDA): a technique for invasive endoscopic procedures. Br J Urol 79: 4141\u2013420","journal-title":"Br J Urol"},{"key":"1000_CR5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0090-4295(99)00498-7","volume":"55","author":"Fowler","year":"2000","unstructured":"Fowler CJ (2000) Intravesical treatment of overactive bladder. Urology 55(Suppl 5A): 60\u201364","journal-title":"Urology"},{"key":"1000_CR6","first-page":"486","volume":"48","author":"Fr","year":"1998","unstructured":"Fr\u00f6hlich G, Burmeister S, Wiedemann A, Bulitta M (1998) Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test. Arzneimittelforschung 48: 486\u2013491","journal-title":"Arzneimittelforschung"},{"key":"1000_CR7","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0022-5347(01)66793-4","volume":"154","author":"Geirssson","year":"1995","unstructured":"Geirssson G, Fall M, Sullivan L (1995) Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia. J Urol 154: 1825\u20131829","journal-title":"J Urol"},{"key":"1000_CR8","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/S0022-5347(05)65183-X","volume":"167","author":"Giannantoni","year":"2001","unstructured":"Giannantoni A, Di Stasi S, Stephen RL, Navarra P, Scivoletto G, Mearini E, Porena M (2001) Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized trial. J Urol 167: 1710\u20131714","journal-title":"J Urol"},{"key":"1000_CR9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","volume":"172","author":"Giannantoni","year":"2004","unstructured":"Giannantoni A, Di Stasi SM, Stephen RL (2004) Intravesical resiniferatoxin versus botulinum-A-toxin injections for neurogenic detrusor overactivity: a prospective randomized study. J Urol 172: 240\u2013243","journal-title":"J Urol"},{"key":"1000_CR10","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0022-5347(01)65638-6","volume":"156","author":"Gurpinar","year":"1996","unstructured":"Gurpinar T, Truong LD, Wong HY, Griffith DP (1996) Electromotive drug administration to the urinary bladder: an animal model and prelinminary results. J Urol 156: 1496\u20131501","journal-title":"J Urol"},{"key":"1000_CR11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","volume":"46","author":"Haferkamp","year":"2004","unstructured":"Haferkamp A, Schurch B, Reitz A et al. (2004) Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder. Eur Urol 46: 784\u2013791","journal-title":"Eur Urol"},{"key":"1000_CR12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00120-005-0769-9","volume":"44","author":"Hampel","year":"2005","unstructured":"Hampel C, Gillitzer R, Pahernik S, Melchior SW, Th\u00fcroff JW (2005) Medikament\u00f6se Therapie der weiblichen Harninkontinenz. Urologe A 44: 244\u2013255","journal-title":"Urologe A"},{"key":"1000_CR13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/nau.10157","volume":"23","author":"Hinkel","year":"2004","unstructured":"Hinkel, A, Pannek J (2004) Transient ischemic attack after electromotive drug administration for chronic non-infectious cystitis: Report of two similar cases. Neurourol Urodyn 23: 180\u2013182","journal-title":"Neurourol Urodyn"},{"key":"1000_CR14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","volume":"75","author":"Jankovic","year":"2004","unstructured":"Jankovic J (2004) Botulinum toxin in clinical practice. J Neurol Neurosurg Psychiatry 75: 951\u2013957","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1000_CR15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/01.ju.0000081652.31524.27","volume":"170","author":"Kuo","year":"2003","unstructured":"Kuo HC (2003) Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions. J Urol 170: 835\u2013839","journal-title":"J Urol"},{"key":"1000_CR16","first-page":"1135","volume":"43","author":"Loch","year":"2004","unstructured":"Loch A, Stein U (2004) Interstitielle Zystitis. Aktuelle Aspekte in der Diagnostik und Therapie. Urologe A 43: 1135\u20131146","journal-title":"Urologe A"},{"key":"1000_CR17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1525-1594.1993.tb00378.x","volume":"17","author":"Lugnani","year":"1993","unstructured":"Lugnani F, Mazza G, Cerulli N, Rossi C, Stephen R (1993) Iontophoresis of drugs in the bladder wall: equipment and preliminary studies. Artif Org 17: 8\u201317","journal-title":"Artif Org"},{"key":"1000_CR18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000475078","volume":"28","author":"Madersbacher","year":"1995","unstructured":"Madersbacher H, Knoll M (1995) Intravesical application of oxybutinine: mode of action in controlling detrusor hyperreflexia. Eur Urol 28: 240\u2013244","journal-title":"Eur Urol"},{"key":"1000_CR19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-5347(17)36663-6","volume":"148","author":"Massad","year":"1992","unstructured":"Massad CA, Kogan BA, Trigo-Rocha FE (1992) The pharmacogenetics of intravesical and oral oxybutinin chloride. J Urol 148: 595\u2013597","journal-title":"J Urol"},{"key":"1000_CR20","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/mds.20376","volume":"20","author":"Mejia","year":"2005","unstructured":"Mejia NI, Dat Vuong K, Jankovic J (2005) Long term botulinum toxin efficacy, safety, and immunogenicity. Move Dis 20: 592\u2013597","journal-title":"Move Dis"},{"key":"1000_CR21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/nau.1930090211","volume":"9","author":"Mohler","year":"1990","unstructured":"Mohler JL (1990) Relaxation of intestinal bladders by intravesical oxybutinin chloride. Neurourol Urodynam 9: 179\u2013187","journal-title":"Neurourol Urodynam"},{"key":"1000_CR22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1464-410X.1993.tb16255.x","volume":"72","author":"Prasad","year":"1993","unstructured":"Prasad KVR, Vaidyanathan S (1993) Intravesical oxybutinin chloride and clean intermittent catheterisation in patients with neurogenic vesical dysfunction and decreased bladder capacity. Br J Urol 72: 719\u2013722","journal-title":"Br J Urol"},{"key":"1000_CR23","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"Reitz","year":"2004","unstructured":"Reitz A, St\u00f6hrer M, Kramer G et al. (2004) European xperience of 200 cases treated with Botulinum-A Toxin Injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45: 510\u2013515","journal-title":"Eur Urol"},{"key":"1000_CR24","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/S0022-5347(01)63174-4","volume":"159","author":"Riedl","year":"1998","unstructured":"Riedl CR, Knoll M, Plas E, Pfluger H (1998) Intravesical electromotive drug administration technique: preliminary results and side effects. J Urol 159: 1851\u20131856","journal-title":"J Urol"},{"key":"1000_CR25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02764846","volume":"8","author":"Rosamilia","year":"1997","unstructured":"Rosamilia A, Dwyer PL, Gibson J (1997) Electromotive drug administration of lidocaine and dexomethasone followed by cytodistention in women with interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 8(3): 142\u2013145","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"1000_CR26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/nau.20106","volume":"24","author":"Rose","year":"2005","unstructured":"Rose AE, Payne CK, Azevedo K (2005) Pilot study of the feasibility of in-office bladder distension using electromotive drug administration (EMDA). Neurourol Urodyn 24: 254\u2013260","journal-title":"Neurourol Urodyn"},{"key":"1000_CR27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"Schurch","year":"2000","unstructured":"Schurch B, St\u00f6hrer M, Kramer G, Schmid DM, Gaul G, Hauri D (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164: 692\u2013697","journal-title":"J Urol"},{"key":"1000_CR28","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00120-004-0652-0","volume":"43","author":"Schurch","year":"2004","unstructured":"Schurch B, Reitz A (2004) Botulinumtoxin in der Urologie. Indikationen und Ergebnisse. Urologe A 43: 1410\u20131415","journal-title":"Urologe A"},{"key":"1000_CR29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.sc.3101593","volume":"42","author":"Schurch","year":"2004","unstructured":"Schurch B, Reitz A, Tenti G (2004) Electromotive drug administration of lidocaine to anesthetize the bladder before botulinum-A toxin injections into the detrusor. Spinal Cord 42: 338\u2013341","journal-title":"Spinal Cord"},{"key":"1000_CR30","first-page":"30","volume":"41","author":"Schultz-Lampel","year":"2002","unstructured":"Schultz-Lampel, D, Wei\u00dfhaar I, Lampel A (2002) EMDA-Therapie bei interstitieller Zystitis, therapierefrakt\u00e4rem Urge- und pelvic pain Syndrom. Urologe A 41(Suppl 1): 30","journal-title":"Urologe A"},{"key":"1000_CR31","unstructured":"Schultz-Lampel (2003) Konservative Prim\u00e4rtherapie vor allem bei IC. Urologische Nachrichten 19.11.2003"},{"key":"1000_CR32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-5347(05)64683-6","volume":"168","author":"Silva","year":"2002","unstructured":"Silva C, Ribeiro MJ, Cruz F (2002) The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input. J Urol 168: 575\u2013579","journal-title":"J Urol"},{"key":"1000_CR33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0031-6997(24)01403-0","volume":"51","author":"Szallasi","year":"1999","unstructured":"Szallasi A, Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159\u2013212","journal-title":"Pharmacol Rev"},{"key":"1000_CR34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/(SICI)1520-6777(1999)18:5<447::AID-NAU6>3.0.CO;2-Q","volume":"18","author":"Walter","year":"1999","unstructured":"Walter P, Grosse J, Bihr AM, Kramer G, Schulz HU, Schwantes U, St\u00f6hrer M (1999) Bioavailability of trospium chloride after intravesical instillation in patients with neurogenic lower urinary tract dysfunction: A pilot study. Neurourol Urodyn 18: 447\u2013453","journal-title":"Neurourol Urodyn"},{"key":"1000_CR35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0090-4295(93)90098-U","volume":"41","author":"Weese","year":"1993","unstructured":"Weese DL, Roskamp DA, Leach GE, Zimmern, PE (1993) Intravesical oxybutynin chloride: experience with 42 patients. Urology 41: 527\u2013530","journal-title":"Urology"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-006-1000-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-006-1000-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-006-1000-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T13:26:46Z","timestamp":1736256406000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-006-1000-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["1000"],"URL":"https:\/\/doi.org\/10.1007\/s00120-006-1000-3","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"type":"print","value":"0340-2592"},{"type":"electronic","value":"1433-0563"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}